Free Trial

Delek US (NYSE:DK) Upgraded to "Hold" at Wall Street Zen

Delek US logo with Energy background

Key Points

  • Delek US has been upgraded from a "sell" rating to a "hold" rating by analysts at Wall Street Zen.
  • Investment analysts have varying opinions on Delek US, with a consensus target price of $27.69 and ratings ranging from "buy" to "sell".
  • The company's recent quarterly earnings report showed a loss of ($0.56) earnings per share, which was better than expected, but revenue declined by 16.4% year-over-year.
  • Interested in Delek US? Here are five stocks we like better.

Delek US (NYSE:DK - Get Free Report) was upgraded by analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued on Friday.

Several other equities research analysts have also commented on DK. Bank of America boosted their price target on shares of Delek US from $14.00 to $24.00 and gave the company an "underperform" rating in a report on Wednesday, September 3rd. Citigroup restated a "neutral" rating and issued a $30.00 price target (up previously from $15.00) on shares of Delek US in a report on Wednesday, July 16th. Morgan Stanley set a $34.00 price target on shares of Delek US and gave the company an "equal weight" rating in a report on Friday. TD Cowen upgraded shares of Delek US from a "sell" rating to a "hold" rating and boosted their price target for the company from $15.00 to $28.00 in a report on Friday, September 19th. Finally, The Goldman Sachs Group boosted their price target on shares of Delek US from $25.00 to $28.00 and gave the company a "neutral" rating in a report on Monday, September 15th. Three investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $27.69.

Get Our Latest Report on DK

Delek US Trading Down 0.1%

Shares of DK stock traded down $0.02 during trading hours on Friday, reaching $32.27. 1,470,244 shares of the stock were exchanged, compared to its average volume of 2,079,730. Delek US has a 12-month low of $11.02 and a 12-month high of $34.50. The company's 50-day moving average price is $27.13 and its 200-day moving average price is $21.28. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of -2.63 and a beta of 1.01. The company has a current ratio of 0.80, a quick ratio of 0.50 and a debt-to-equity ratio of 10.48.

Delek US (NYSE:DK - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The oil and gas company reported ($0.56) earnings per share for the quarter, beating analysts' consensus estimates of ($0.92) by $0.36. Delek US had a negative net margin of 7.11% and a negative return on equity of 79.27%. The company had revenue of $2.76 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter last year, the business posted ($0.92) EPS. The firm's revenue for the quarter was down 16.4% on a year-over-year basis. As a group, equities analysts anticipate that Delek US will post -5.5 earnings per share for the current year.

Insiders Place Their Bets

In other Delek US news, CFO Robert G. Wright sold 7,135 shares of the business's stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $29.24, for a total transaction of $208,627.40. Following the sale, the chief financial officer owned 48,294 shares of the company's stock, valued at approximately $1,412,116.56. The trade was a 12.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.80% of the company's stock.

Institutional Trading of Delek US

Several large investors have recently bought and sold shares of DK. T. Rowe Price Investment Management Inc. purchased a new stake in Delek US during the 1st quarter worth approximately $13,728,000. Nuveen LLC purchased a new stake in Delek US during the 1st quarter worth approximately $13,629,000. Harel Insurance Investments & Financial Services Ltd. grew its position in Delek US by 113.5% during the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,601,777 shares of the oil and gas company's stock worth $33,926,000 after purchasing an additional 851,458 shares during the last quarter. Callodine Capital Management LP boosted its holdings in shares of Delek US by 1,827.6% in the 1st quarter. Callodine Capital Management LP now owns 674,661 shares of the oil and gas company's stock valued at $10,167,000 after acquiring an additional 639,661 shares during the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of Delek US by 144.3% in the 2nd quarter. Bank of America Corp DE now owns 632,695 shares of the oil and gas company's stock valued at $13,400,000 after acquiring an additional 373,678 shares during the last quarter. Hedge funds and other institutional investors own 97.01% of the company's stock.

About Delek US

(Get Free Report)

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.

Featured Articles

Analyst Recommendations for Delek US (NYSE:DK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Delek US Right Now?

Before you consider Delek US, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.

While Delek US currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.